Metabolic vulnerability of cisplatin‐resistant cancers

Florine Obrist; Judith Michels; Sylvère Durand; Alexis Chery; Jonathan Pol; Sarah Lévesque; Adrien Joseph; Valentina Astesana; Federico Pietrocola; Gen Sheng Wu; Maria Castedo; Guido Guido Kroemer

doi:10.15252/embj.201798597

Related publications

Article2020

Abstract A75: Serine auxotrophy: A novel metabolic vulnerability of platinum-resistant ovarian cancer?

Tom Van Nyen, João Duarte, Matteo Rossi, Mélanie Planque, Esther A. Zaal, Ali Talebi, Stijn Moens, Guy Eelen, Hugo M. Horlings, Johan Swinnen, Celia R. Berkers, Peter Carmeliet, Reuven Agami, Sarah‐Maria Fendt, Diether Lambrechts, Daniela Annibali, Frédéric Amant

Article2014

MCL-1 dependency of cisplatin-resistant cancer cells

Judith Michels, Florine Obrist, Ilio Vitale, Delphine Lissa, Pauline Garcia, Parviz Behnam‐Motlagh, Kimitoshi Kohno, Gen Sheng Wu, Catherine Brenner, Maria Castedo, Guido Guido Kroemer

Article2018

Cisplatin resistance coupled to enhanced sensitivity to metabolic interventions

Maria Castedo, Florine Obrist, Guido Guido Kroemer

Article2022

The lipid flippase SLC47A1 blocks metabolic vulnerability to ferroptosis

Zhi Lin, Jiao Liu, Fei Long, Rui Kang, Guido Guido Kroemer, Daolin Tang, Minghua Yang

Article2020

Platinum-AIEgen coordination complex for imaging-guided annihilation of cisplatin-resistant cancer cells

Zhenyan He, Yuting Gao, Haoke Zhang, Xiuxia Wang, Fanling Meng, Liang Luo, Ben Zhong Tang